Detalhe da pesquisa
1.
International Society for Cell and Gene Therapy of Cancer: 2005 meeting in Shenzhen, China.
Cancer Gene Ther
; 14(2): 128-38, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17041563
2.
Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy.
Cancer Gene Ther
; 14(7): 599-615, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17479105
3.
A novel MHC-associated proteinase 3 peptide isolated from primary chronic myeloid leukaemia cells further supports the significance of this antigen for the immunotherapy of myeloid leukaemias.
Leukemia
; 20(6): 1067-72, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16628186
4.
Frequent expression of HAGE in presentation chronic myeloid leukaemias.
Leukemia
; 16(11): 2238-42, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12399967
5.
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up.
Leukemia
; 12(6): 887-92, 1998 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-9639416
6.
Changing p53 mutations with the evolution of chronic myeloid leukaemia from the chronic phase to blast crisis.
Leuk Res
; 19(8): 519-25, 1995 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-7658697
7.
Elevated levels of p53 protein in the neutrophils and monocytes of a patient with chronic idiopathic thrombocytopenic purpura or possible early myelodysplasia?
Leuk Res
; 19(10): 727-31, 1995 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-7500649
8.
Increasing methylation of the calcitonin gene during disease progression in sequential samples from CML patients.
Leuk Res
; 20(9): 771-5, 1996 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-8947587
9.
p53 mutations, methylation and genomic instability in the progression of chronic myeloid leukaemia.
Leuk Lymphoma
; 26(3-4): 211-26, 1997 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-9322884
10.
An in vivo and in vitro comparison of the effects of b2-a2 and b3-a2 p210BCR-ABL splice variants on murine 32D cells.
Leuk Lymphoma
; 37(3-4): 393-404, 2000 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10752991
11.
The innovative evolution of cancer gene and cellular therapies.
Cancer Gene Ther
; 20(3): 141-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23370333
12.
New targets for the immunotherapy of colon cancer-does reactive disease hold the answer?
Cancer Gene Ther
; 20(3): 157-68, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23492821
13.
International progress in cancer gene therapy.
Cancer Gene Ther
; 15(12): 765-75, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18846114
14.
Characterization of the human B cell RAG-associated gene, hBRAG, as a B cell receptor signal-enhancing glycoprotein dimer that associates with phosphorylated proteins in resting B cells.
J Biol Chem
; 275(28): 20967-79, 2000 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-10749872
15.
4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine.
J Immunol
; 162(8): 5003-10, 1999 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-10202049
16.
Expression of Factor IX cDNA Introduced into Human Marrow Stromal Cells by Electroporation.
Hematology
; 3(5): 347-54, 1998.
Artigo
em Inglês
| MEDLINE | ID: mdl-27414078
17.
4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors.
Cell Immunol
; 210(1): 56-65, 2001 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-11485353
18.
p53 mutations indicate a changing clonal evolution in a portion of chronic myelocytic leukemia patients.
Blood
; 84(10): 3591, 1994 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-7949113